España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Aytu BioPharma
AYTU
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$1.38
0.00
0.00%
At close: -
$1.39
0.01
0.72%
After Hours: Dec 16, 4:59 PM EDT
Get Report
Comment
Aytu BioPharma (AYTU) Forecast
News
Earnings
Aytu BioPharma (AYTU) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Aytu BioPharma (NASDAQ:AYTU) Stock
Aytu BioPharma Stock (NASDAQ: AYTU)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, November 14, 2024
Aytu BioPharma shares are trading lower. The ...
Benzinga Newsdesk
Wednesday, November 13, 2024
Aytu Biopharma Said On November 11 Terminated...
Benzinga Newsdesk
Aytu BioPharma Q1 2025 GAAP EPS $(0.20) Beats...
Benzinga Newsdesk
Earnings Scheduled For November 13, 2024
Benzinga Insights
Tuesday, November 12, 2024
Aytu BioPharma's Earnings: A Preview
Benzinga Insights
Tuesday, October 01, 2024
Aytu BioPharma Signs Exclusive Agreement With...
Benzinga Newsdesk
Friday, September 27, 2024
Aytu BioPharma shares are trading lower after...
Benzinga Newsdesk
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Thursday, September 26, 2024
Aytu BioPharma shares are trading lower after...
Benzinga Newsdesk
Aytu BioPharma Q4 2024 GAAP EPS $(0.82) Misse...
Benzinga Newsdesk
Aytu BioPharma FY 2024 GAAP EPS $(2.86) Misse...
Benzinga Newsdesk
Tuesday, August 06, 2024
Aytu BioPharma Announces Sale Of Consumer Hea...
Benzinga Newsdesk
Wednesday, May 15, 2024
Aytu BioPharma Q3 2024 GAAP EPS $(0.52) Beats...
Benzinga Newsdesk
Wednesday, February 14, 2024
Aytu BioPharma Q2 2024 GAAP EPS $(0.04) Beats...
Benzinga Newsdesk
Earnings Scheduled For February 14, 2024
Benzinga Insights
Tuesday, February 13, 2024
Earnings Preview: Aytu BioPharma
Benzinga Insights
Wednesday, November 22, 2023
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Wednesday, November 15, 2023
Why Shapeways Holdings Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
Tuesday, November 14, 2023
Aytu BioPharma Q1 EPS $(1.48) Down From $(1.2...
Benzinga Newsdesk
Earnings Scheduled For November 14, 2023
Benzinga Insights
Monday, November 13, 2023
Aytu BioPharma's Earnings: A Preview
Benzinga Insights
Monday, November 06, 2023
Biggest Short Squeeze Stocks Of The Week: Biotech Stocks Dominate, A Bitcoin-Related Stock Moves Up Leaderboard
Chris Katje
Thursday, October 26, 2023
Aytu BioPharma Announces Approval Of The Cote...
Benzinga Newsdesk
Thursday, September 28, 2023
Aytu Biopharma shares are trading higher afte...
Benzinga Newsdesk
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
Why CarMax Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Lisa Levin
Reported September 27, Aytu BioPharma Q4 EPS $(0.59) Beats $(0.95) Estimate, Sales $30.73M Beat $27.69M Estimate
Happy Mohamed
Wednesday, September 27, 2023
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Earnings Scheduled For September 27, 2023
Benzinga Insights
Tuesday, September 26, 2023
Earnings Outlook For Aytu BioPharma
Benzinga Insights
Thursday, August 24, 2023
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Monday, August 21, 2023
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
Friday, August 18, 2023
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Wednesday, August 16, 2023
Aytu BioPharma Chief Commercial Officer Awarded $12K Worth of Stock Options
Benzinga Insights
Chief Financial Officer at Aytu BioPharma Acquires Company Stock Options Worth 13,000 Shares
Benzinga Insights
Aytu BioPharma Chief Operating Officer Awarded $12K Worth of Stock Options
Benzinga Insights
Aytu BioPharma Chief Executive Officer Awarded $64K Worth of Stock Options
Benzinga Insights
Chief Business Officer at Aytu BioPharma Acquires Company Stock Options Worth 7,000 Shares
Benzinga Insights
Wednesday, August 09, 2023
Benzinga's Top Ratings Upgrades, Downgrades For August 9, 2023
Benzinga Insights
Maxim Group Initiates Coverage On Aytu BioPha...
Benzinga Newsdesk
Monday, July 31, 2023
Aytu BioPharma Announces Exclusive Agreement With Medomie Pharma Ltd. To Commercialize Adzenys XR-ODT And Cotempla XR-ODT In Israel And The Palestinian Authority
Happy Mohamed
Monday, July 10, 2023
Aytu BioPharma Announces Submission Of Cotempla XR-ODT Manufacturing Site Transfer Prior Approval Supplement
Happy Mohamed
Friday, June 16, 2023
Star Equity Holdings And 2 Other Stocks Under $2 Insiders Are Aggressively Buying
Lisa Levin
Friday, June 09, 2023
Aytu BioPharma Announces Pricing Of $4M Publi...
Benzinga Newsdesk
Wednesday, May 31, 2023
HC Wainwright & Co. Reiterates Buy on Aytu Bi...
Benzinga Newsdesk
Friday, May 26, 2023
Aytu BioPharma 13D Filing Shows Nantahala Capital Management, LLC Increased Stake In Co 7.2%
Happy Mohamed
Thursday, May 11, 2023
Aytu BioPharma: Q3 Earnings Insights
Benzinga Insights
Aytu BioPharma Q3 EPS $(1.93) Misses $(0.63) ...
Benzinga Newsdesk
Earnings Scheduled For May 11, 2023
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch